EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 191 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,713,000 | +43.6% | 22,636 | +0.0% | 0.21% | +36.3% |
| Q1 2018 | $1,193,000 | -10.4% | 22,634 | -9.2% | 0.16% | -10.8% |
| Q4 2017 | $1,332,000 | -7.9% | 24,935 | +2.8% | 0.18% | -10.7% |
| Q3 2017 | $1,447,000 | -33.0% | 24,265 | -11.3% | 0.20% | -36.2% |
| Q2 2017 | $2,159,000 | +18.4% | 27,361 | +24.4% | 0.31% | +8.0% |
| Q1 2017 | $1,824,000 | +17.3% | 21,994 | +12.2% | 0.29% | +11.7% |
| Q4 2016 | $1,555,000 | +53.1% | 19,603 | +35.0% | 0.26% | +56.1% |
| Q3 2016 | $1,016,000 | – | 14,521 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |